Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- Use of contraception in the United States: 1982-2008.Vital Health Stat 23. 2010; 29: 1-44
- Validation of a decisional conflict scale.Med Decis Making. 1995; 15: 25-30
- Contraceptive features preferred by women at high risk of unintended pregnancy.Perspect Sex Reprod Health. 2012; 44: 194-200
- International survey to assess women's attitudes regarding choice of daily versus nondaily female hormonal contraception.Int J Womens Health. 2014; 6: 367-375
- What matters most? The content and concordance of patients' and providers' information priorities for contraceptive decision making.Contraception. 2014; 90: 280-287
- Contraceptive characteristics: the perceptions and priorities of men and women.Fam Plann Perspect. 1999; 31: 168-175
- Consistency between most important reasons for using contraception and current method used: the influence of health care providers.Contraception. 2006; 73: 399-403
- Contraceptive failure in the United States.Contraception. 2011; 83: 397-404
- The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.Am J Obstet Gynecol. 2010; 203: 115.e1-115.e7
- Structured contraceptive counseling provided by the Contraceptive CHOICE Project.Contraception. 2013; 88: 243-249
- Preventing unintended pregnancies by providing no-cost contraception.Obstet Gynecol. 2012; 120: 1291-1297
- Changes in use of long-acting contraceptive methods in the United States, 2007-2009.Fertil Steril. 2012; 98: 893-897
- Strategies to improve adherence and acceptability of hormonal methods of contraception.Cochrane Database Syst Rev. 2011; 4: CD004317
- Advance information improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol. 2002; 99: 608-613
- Tailored health messaging improves contraceptive continuation and adherence: results from a randomized controlled trial.Contraception. 2012; 86: 536-542
This research was supported in part by a grant from the Society of Family Planning award number 3-1 and by award number K23HD070979 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development . Neither funding source had any role in the study design; the collection, analysis, or interpretation of data; or the decision to submit for publication.
T.M. serves on a scientific advisory board for Bayer Healthcare Pharmaceuticals and on a data safety monitoring board for phase-IV safety studies of Bayer contraceptive products. R.N. was employed by Express Scripts at the time of the study. M.P. was previously on the US Medication Adherence Advisory Board for Merck & Co, Inc (2011 through 2013) and currently has an investigator-initiated research grant funded by Merck & Co, Inc (2014 through 2015). J.F.P. receives research funding from Bayer Healthcare Pharmaceuticals, TEVA Pharmaceuticals, and Merck & Co, Inc, and serves on an advisory boards for Bayer Healthcare Pharmaceuticals, TEVA Pharmaceuticals, and MicroCHIPS. G.M.S. reports no potential conflict of interest.
Cite this article as: Madden T, Secura GM, Nease RF, et al. The role of contraceptive attributes in women’s contraceptive decision making. Am J Obstet Gynecol 2015;213:46.e1-6.